LAHORE: A report of the second special medical board that surfaced on Wednesday after the last week examination of former prime minister Nawaz Sharif inside the jail has recommended his treatment at hospital for ‘optimal management’.

A four-member (second) special medical board of Allama Iqbal Medical College/Jinnah Hospital in its report, a copy of which is available with Dawn, also recommended some changes to his medicines to control blood pressure and diabetes besides further tests.

Mr Sharif is serving seven-year imprisonment in the Al-Azizia Steel Mills case in Kot Lakhpat jail.

“Given uncontrolled BP, stage 3 CKD with estimated GFR of 50 ml/ min, borderline raised troponin T level with significant history of ischemic heart disease and suboptimal care, Nawaz Sharif will benefit from hospitalisation so that optimal management and cardiac assessment can be initia­ted,” said the board comprising AIMC principal Prof Dr Arif Tajammul (chairman), Prof Dr Tanveerul Islam, Prof Dr Aamir Nadeem and Prof Dr Shafiq Cheema.

The board said Nawaz Sharif with past medical history of hypertension, T2 diabetes mellitus, ischemic heart disease and CABGH, kidney stone disease complained about post nasal drip, bilateral arm, shoulder pain and some dyspnoea on exertion.

“On physical examination he was found to have BP 200/110 mm Hg. Morning blood pressure medicines were not taken and BP decreased to 160/90 mm Hg after tablet concor and dozar were given, heart rate 64 /min oxygen saturation of 98 per cent with clear chest, normal cardiac, abdominal examination and no pitting edema on lower extremities.”

It said recent laboratory data was significant for some non-specific ST-T changes, LBBB, serum creatinine 1.4, Bicarbonate of 17, HBAIC 7.2 and urine complete showing one plus protein.

“In our assessment the patient (Sharif) has stage 3 CKD problem, secondary to diabetic nephropathy and HTN, uncontrolled HTN and mild proteinuria, suboptimal T2 diabetes control, metabolic acidosis, post-nasal drip and nasal allergies, fatty liver, nephrolithiasis and benign renal cysts, rule out secondary hyperparathyroidism and bone disease, and underling IHD with recent rise in Trop T level,” the report stated.

Published in Dawn, January 24th, 2019